Medicare Enrolled
Dr. Ralph Russo, M.D.
Cardiovascular Disease · Moorestown, NJ
Practice pattern: Electrophysiology & Device
— Practice focused on heart rhythm disorders and cardiac device management
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Russo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Russo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Russo
Dr. Ralph Russo is a cardiovascular disease specialist in Moorestown, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Russo performed 7,664 Medicare services across 5,468 unique beneficiaries.
Between the years covered by Open Payments, Dr. Russo received a total of $10,481 from 35 pharmaceutical and/or device companies across 589 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Russo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in NJ
$10,481 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,664
Medicare services
Top 5% in NJ for cardiovascular disease
5,468
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~383 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,554 | $11 | $55 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,454 | $97 | $284 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
1,193 | $6 | $25 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
455 | $117 | $521 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
397 | $67 | $163 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
334 | $101 | $239 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
202 | $147 | $430 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
178 | $4 | $11 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
163 | $19 | $85 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
160 | $45 | $148 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
139 | $31 | $124 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
127 | $57 | $300 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
123 | $24 | $100 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
113 | $164 | $680 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
98 | $52 | $235 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
98 | $19 | $85 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
94 | $261 | $1,073 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
70 | $129 | $365 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
66 | $61 | $215 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
64 | $21 | $84 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
55 | $12 | $50 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
55 | $146 | $231 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
54 | $18 | $70 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
50 | $138 | $640 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
49 | $20 | $85 |
| Physician review of home INR testing A physician reviews, interprets, and manages home INR testing results for patients with mechanical heart valves, chronic atrial fibrillation, or venous thromboembolism who meet Medicare coverage criteria. |
45 | $7 | $30 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
44 | $100 | $455 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
40 | $27 | $145 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
39 | $213 | $870 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
35 | $111 | $291 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $134 | $395 |
| 2-day continuous ECG monitoring A continuous electrocardiogram recording that captures heart activity over a 48-hour period. This test helps detect irregular heart rhythms or other cardiac issues that may not appear during a standard, short-term ECG. |
23 | $15 | $97 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
23 | $15 | $85 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
14 | $9 | $27 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
12 | $162 | $660 |
| Heart muscle strain imaging | 11 | $10 | $135 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.7% high complexity
9.8% medium
78.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,481
Total received (2018-2024)
Avg $1,497/year across 7 years
Top 19% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
589
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,327 (79.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,400 (13.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$754 (7.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,253
2023
$3,109
2022
$696
2021
$1,541
2020
$647
2019
$1,992
2018
$1,242
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$242
Amgen Inc.
$132
Impulse Dynamics (USA) Inc.
$124
Boston Scientific Corporation
$100
Janssen Pharmaceuticals, Inc
$96
Boehringer Ingelheim Pharmaceuticals, Inc.
$75
AstraZeneca Pharmaceuticals LP
$67
Merck Sharp & Dohme LLC
$61
Kiniksa Pharmaceuticals International, plc
$54
Philips North America LLC
$47
SCPHARMACEUTICALS INC.
$42
Kestra Medical Technology Services, Inc.
$35
Esperion Therapeutics, Inc.
$32
ABIOMED
$28
Lexicon Pharmaceuticals, Inc.
$18
PFIZER INC.
$18
Regeneron Healthcare Solutions, Inc.
$17
Alnylam Pharmaceuticals Inc.
$17
AGEPHA Pharma FZ LLC
$16
Actelion Pharmaceuticals US, Inc.
$16
E.R. Squibb & Sons, L.L.C.
$14
Top 3 companies account for 39.8% of 2024 payments
All-time payments by company (2018-2024) ›
SCPHARMACEUTICALS INC.
$1,442
Amgen Inc.
$1,237
Impulse Dynamics (USA) Inc.
$1,206
Janssen Pharmaceuticals, Inc
$1,050
E.R. Squibb & Sons, L.L.C.
$890
Boston Scientific Corporation
$804
PFIZER INC.
$754
AstraZeneca Pharmaceuticals LP
$629
Boehringer Ingelheim Pharmaceuticals, Inc.
$366
Novartis Pharmaceuticals Corporation
$314
SANOFI-AVENTIS U.S. LLC
$250
Merck Sharp & Dohme LLC
$210
Gilead Sciences, Inc.
$192
Kowa Pharmaceuticals America, Inc.
$131
Esperion Therapeutics, Inc.
$124
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$116
Amarin Pharma Inc.
$110
Philips Electronics North America Corporation
$85
Regeneron Healthcare Solutions, Inc.
$83
Edwards Lifesciences Corporation
$69
Kiniksa Pharmaceuticals International, plc
$54
Kestra Medical Technology Services, Inc.
$53
Philips North America LLC
$47
GE HealthCare
$36
BOSTON SCIENTIFIC CORPORATION
$32
ABIOMED
$28
Merck Sharp & Dohme Corporation
$26
Avinger Inc.
$24
Abbott Laboratories
$21
Lexicon Pharmaceuticals, Inc.
$18
Kiniksa Pharmaceuticals, Ltd.
$17
Alnylam Pharmaceuticals Inc.
$17
AGEPHA Pharma FZ LLC
$16
Actelion Pharmaceuticals US, Inc.
$16
W. L. Gore & Associates, Inc.
$13
Top 3 companies account for 37.1% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (9124) LM Undivided · AMVUTTRA · Alere i · Arcalyst · Assure WCD · BRILINTA · CAMZYOS · CHANTIX · Corlanor · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMBLEM · ENTRESTO · EVKEEZA · FARXIGA · FUROSCIX · GORE CARDIOFORM Septal Occluder · Impella · JARDIANCE · LEQVIO · LODOCO · LUX DX · LUX-DX · LifeVest · Livalo · MULTAQ · NEXLETOL · NEXLIZET · OPSUMIT · OPTIMIZER · Optimizer · Optimizer Smart System · PANTHERIS · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Ranexa · Repatha · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (79%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
688
Per 100K population
148.2
County median income
$105,271
Nearest hospital
VIRTUA WILLINGBORO HOSPITAL
4.4 mi
4.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Russo is an electrophysiology & device specialist, with above-average Medicare volume (top 5% in NJ), with low-engagement industry engagement in the top 19% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Russo experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Russo performed 1,554 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Russo receive payments from pharmaceutical companies?
Yes. Dr. Russo received a total of $10,481 from 35 companies across 589 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Russo's costs compare to other cardiologists in Moorestown?
Dr. Russo's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Russo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Moorestown
Browse cardiologists in Moorestown ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
SCPHARMACEUTICALS INC. Payments to Doctors
See all physicians who received payments from SCPHARMACEUTICALS INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Impulse Dynamics (USA) Inc. Payments to Doctors
See all physicians who received payments from Impulse Dynamics (USA) Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology